Insider trade

Collegium Pharmaceutical, Inc. (COLL)Officer sold ~$185K

Scott Dreyer, Officer at Collegium Pharmaceutical, Inc., sold ~$185K of Collegium Pharmaceutical, Inc. shares.

~$185K
Approx. value · 4,861 sh @ $38.03: 104K
Holds after · shares reported

Traded: Aug 13, 2025
Filed: Aug 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Aug 8, 2025InsiderDirector sold ~$401K of COLL shares in the open market
Aug 13, 2025 · this disclosureInsiderOfficer sold ~$185K of COLL shares in the open market

What came next

Aug 13, 2025Insider10% owner sold ~$946K of COLL shares in the open market
Aug 15, 2025InsiderDirector sold ~$201K of COLL shares in the open market
Aug 18, 2025InsiderOfficer sold ~$626K of COLL shares in the open market
Aug 29, 2025InsiderOfficer sold ~$672K of COLL shares in the open market
Nov 6, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
Nov 6, 2025Insider · 1 personInsiders: 2 sales (~$1.2M)
Nov 12, 2025InsiderDirector sold ~$1.65M of COLL shares in the open market
Dec 5, 2025InsiderDirector sold ~$172K of COLL shares in the open market
Dec 8, 2025Insider · 1 personInsiders: 2 sales (~$848K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Collegium Pharmaceutical, Inc.

For Collegium Pharmaceutical, Inc., OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COLL page.

Other recent filings by Scott Dreyer, EVP & Chief Commercial Officer

The full history of Scott Dreyer, EVP & Chief Commercial Officer is on the profile page.

How this filing works

Other disclosures at Collegium Pharmaceutical, Inc.

Everything OQRO holds on this company is on its COLL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data